1-1 of 1
Thorsten Kragh
Close
Sort by
Journal Articles

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

Luise Goldmann, Rundan Duan, Thorsten Kragh, Georg Wittmann, Christian Weber, Reinhard Lorenz, Philipp von Hundelshausen, Michael Spannagl, Wolfgang Siess
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4021–4033.
https://doi.org/10.1182/bloodadvances.2019000617
Published: 2019
Includes: Supplemental data